Pfizer investigates death in US that may be vaccine-related

Pfizer Inc. and federal health authorities in the United States are investigating the death of a medical professional, which occurred 16 days after the person received the first dose of the Covid-19 vaccine.

So far, the evidence does not suggest a link, he said. Pfizer Tuesday, January 12 in a press release. The Florida-based doctor has developed a rare condition called severe thrombocytopenia, It decreases the body’s ability to clot blood and stop internal bleeding.

Pfizer cited its clinical trials and data collected since the vaccine was licensed in the United States and reported its initial conclusion thatEvidence does not suggest a causal association with the vaccine which he developed in collaboration with the German company, BioNTech SE.

Pfizer and BioNTech raise target for covid vaccines to 2 billion doses

Meanwhile, the Centers for Disease Control and Prevention (CDC, for its acronym in English), said they were aware of the death, and that they “will assess the situation as more information becomes available. will be available, ”according to his spokesperson. , Tom Skinner.

“To date, millions of people have been vaccinated and we are closely monitoring all adverse events in people receiving our vaccine,” Pfizer said in its statement. “It is important to note that serious adverse events, including deaths that are not related to the vaccine, unfortunately can occur at a rate similar to what would occur in the general population,” the company said.

Coronavirus: They advise against delaying second dose of Pfizer vaccine for more than 42 days

The newspaper New York Times first reported the news of the death of Gregory Michael, a 56-year-old obstetrician and gynecologist in Miami Beach. The outlet cited a Facebook post written on January 5 by his wife, Heidi Neckelmann, in which it said Michael died of a brain hemorrhage.

On December 14, the Pfizer-BioNTech vaccine was licensed for emergency use in the United States. Health care workers in the United States and those in long-term care facilities were the first to receive it. So far, 9.27 million doses of this vaccine and a second licensed vaccine developed by Moderna Inc. have been administered, according to a state-by-state count from Bloomberg and data from the CDC.